Côte d'Ivoire vs Cuba: Number of isolates tested for extended-spectrum cephalosporins
Côte d'Ivoire
30
in 2018
Cuba
26
in 2018
Côte d'Ivoire rank
42nd
Cuba rank
43rd
Number of isolates tested for extended-spectrum cephalosporins over time
- Côte d'Ivoire
- Cuba
How they compare
Côte d'Ivoire currently reports 30 against 26 in Cuba, a difference of 4.
That makes Côte d'Ivoire's figure about 1.2 times Cuba's.
The two have swapped places 1 time across 6 shared years of data; in 2009 it was Cuba ahead.
Côte d'Ivoire ranks 42nd and Cuba ranks 43rd of 51 countries.
Across the 2 decades both report, Côte d'Ivoire averaged higher in 1 and Cuba in 1.
Head to head by decade
| Decade | Côte d'Ivoire | Cuba | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 10 | 40 | 30 | Cuba |
| 2010s | 46 | 39.6 | 6.4 | Côte d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of isolates tested for extended-spectrum cephalosporins, Côte d'Ivoire or Cuba?
- Côte d'Ivoire, at 30 against 26 in Cuba as of 2018.
- What is the difference in number of isolates tested for extended-spectrum cephalosporins between Côte d'Ivoire and Cuba?
- 4, with Côte d'Ivoire ahead.
- How many years of comparable data are there for Côte d'Ivoire and Cuba?
- 6 years are reported by both, from 2009 to 2018.
- How do Côte d'Ivoire and Cuba rank globally for number of isolates tested for extended-spectrum cephalosporins?
- Côte d'Ivoire ranks 42nd and Cuba ranks 43rd of 51 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of isolates tested for extended-spectrum cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.